Key result
Apigenin inhibits FMDV-mediated cytopathogenic effect and viral replication in vitro by interfering with viral IRES-driven translational activity at the post-entry stage.
Apigenin inhibits FMDV in vitro; leaves open therapeutic potential and requires in vivo validation before any clinical consideration.
Foot-and-mouth disease (FMD) is a highly contagious disease of domestic and wild ruminants that is caused by FMD virus (FMDV). FMD outbreaks have occurred in livestock-containing regions worldwide. Apigenin, which is a flavonoid naturally existing in plant, possesses various pharmacological effects, including anti-inflammatory, anticancer, antioxidant and antiviral activities. Results show that apigenin can inhibit FMDV-mediated cytopathogenic effect and FMDV replication in vitro. Further studies demonstrate the following: (i) apigenin inhibits FMDV infection at the viral post-entry stage; (ii) apigenin does not exhibit direct extracellular virucidal activity; and (iii) apigenin interferes with the translational activity of FMDV driven by internal ribosome entry site. Studies on applying apigein in vivo are required for drug development and further identification of potential drug targets against FDMV infection.
No takes yet. Share an insight, caveat, or question.
Qian et al. (2015) studied Foot-and-mouth disease (FMDV infection). Apigenin was evaluated on FMDV-mediated cytopathogenic effect and FMDV replication in vitro. Apigenin inhibits FMDV-mediated cytopathogenic effect and viral replication in vitro by interfering with viral IRES-driven translational activity at the post-entry stage.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: